CCCC — C4 Therapeutics Share News
0.000.00%
Last trade - 00:00- $391.22m
- $137.56m
- $35.95m
Brief: C4 Therapeutics Appoints Kendra Adams as CFO
U.S. RESEARCH ROUNDUP-Autodesk, Bill Holdings, Zoetis
U.S. RESEARCH ROUNDUP-Caci International, Cyberark Software, Ralph Lauren
C4 Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Brief: C4 Therapeutics Q2 EPS USD -0.73
C4 Therapeutics Inc expected to post a loss of 69 cents a share - Earnings Preview
Brief: Millennium Management LLC Reports 4.8% Passive Stake In C4 Therapeutics As Of July 19
U.S. STOCKS ON THE MOVE-Rivian, Alphabet, Moderna
U.S. STOCKS ON THE MOVE-C4 Therapeutics, Pegasystems, BioMarin Pharma
C4 Therapeutics rises on FDA nod to begin human study for lung cancer drug
Brief: C4 Therapeutics Announces FDA Clearance Of Investigational New Drug Application For CFT8919, An Orally Bioavailable BIDAC Degrader Targeting EGFR L858R For Non-Small Cell Lung Cancer
Brief: C4 Therapeutics Appoints Leonard Reyno, M.D. As Chief Medical Officer
U.S. STOCKS ON THE MOVE-Netflix, Hewlett Packard Enterprise, Digital Realty
U.S. STOCKS ON THE MOVE-AI stocks, Broadcom, T2 Biosystems
C4 Therapeutics rises on cancer treatment deal with Betta Pharma
Brief: C4 Therapeutics And Betta Pharmaceuticals Announce Exclusive Licensing Agreement
Brief: Betta Pharmaceuticals To Invest In C4 Therapeutics
Brief: C4 Therapeutics Q1 revenue USD 3.8 million
C4 Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview